I compared GLP-1 / longevity bloodwork pricing (Ulta, Marek, Mito) - why are labs marked up so much?

ngl the markup on lipid panels is insane, ive been getting them through quest for like half the price of what ulta wants. curious how mito stacks up tho because most "direct to consumer" labs still seem overpriced compared to just walking into a lab yourself. also would def want homocysteine and lp(a) tracked if running glp1s since thats where the cardiovascular risk shows up, not just total cholesterol like boomers think

yeah the markup game is real but honestly most of these "direct to consumer" plays are just middlemen with better marketing. if you actually have insurance and can get referred to a real lab you're already beating most of these prices, people just don't know that. that said the homocysteine/lp(a) thing is legit, been tracking both for like 3 years and way more predictive than the standard lipid garbage they push. curious what their actual numbers are but i've heard this pitch before from other startups.

the thing that actually matters here is whether they're beating insurance + lab visit pricing, and nobody's actually proving that. restwise is right that if you have decent insurance and can get a referral you're already at cost or below. i've run the numbers and my copays for bloodwork through my doctor's preferred lab come out to like $40-60 total per year for most of this stuff. the "at cost" claim doesn't mean much if you're still marking it up from actual wholesale. would need to see itemized pricing on each test compared to what a healthcare provider actually pays before i buy into this being some revolutionary model.

insurance pricing is wild because it varies so much by plan and lab network. some people genuinely get bloodwork for $20 a panel through their deductible or copay structure, others are looking at $200+ per test if they're out of network or have a high deductible. that's why the comparison gets messy.

what actually matters imo is whether the per-test cost beats what you'd pay cash at quest or labcorp if you walked in without insurance. those places have posted cash prices now and they're usually pretty reasonable. if mito's beating those consistently across a full longevity panel then yeah there's something there.

also curious whether they're actually running the tests in-house or just bundling orders from existing labs and reselling. the markup on distribution and aggregation is where a lot of these middleman companies live.

@theoretic wrote: ngl the markup on lipid panels is insane, ive been getting them through quest for like half the price of what ulta wants. curious how mito stacks up tho because most "direct to consumer" labs still seem overpriced compared to just walking into a lab yourself. also would def want homocysteine and lp(a) tracked if running glp1s since thats where the cardiovascular risk shows up, not just total cholesterol like boomers think

Yup! it's pretty much the same thing actually but at much better prices

what we provide is the dashboard and visuals and we're adding alot of support for peptide consumers actually very soon!

digital aspects of the product soon.

@fat_loss_log wrote: the thing that actually matters here is whether they're beating insurance + lab visit pricing, and nobody's actually proving that. restwise is right that if you have decent insurance and can get a referral you're already at cost or below. i've run the numbers and my copays for bloodwork through my doctor's preferred lab come out to like $40-60 total per year for most of this stuff. the "at cost" claim doesn't mean much if you're still marking it up from actual wholesale. would need to see itemized pricing on each test compared to what a healthcare provider actually pays before i buy into this being some revolutionary model.

Every single traditional healthcare provider marks up if they are insurance bill - it's because it's the way the industry is run

to drive up the deductibles so that you pay more and hit it before they cover anything at all.

and labs are the easiest way to do it.

the dashboard stuff is actually pretty useful ngl, tracking trends over time beats just getting a pdf with numbers. peptide-specific support would be clutch since most of these platforms treat gear users like we don't exist. if you're actually hitting those price points on homocysteine and lp(a) consistently that's the real differentiator because those tests are usually where the hidden markup lives.

dashboards are cool but they're kinda table stakes at this point, most decent apps do that already. what im actually interested in is whether you're beating cash walk-in prices at quest/labcorp on individual tests, because that's the real floor. like if homocysteine is $45 at quest cash and you're doing it for $30 consistently then yeah there's real value, but if you're at $40 you're just shuffling deck chairs. would help if you posted actual screenshots of your pricing next to their posted cash prices instead of just saying "20-50% cheaper" because that number gets thrown around constantly without proof.

yeah but that's kind of the whole point right, if you have good insurance you're already winning. the people paying $200+ for panels on ulta are usually the ones without coverage or high deductibles, so comparing to someone's $40/year copay situation doesn't really address the actual problem. the real question is just whether mito beats quest cash prices consistently, and i'm with epi_cycler on needing to see the screenshots.